Back to Search Start Over

Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan.

Authors :
Yasuda, Manato
Uzawa, Akiyuki
Kuwabara, Satoshi
Suzuki, Shigeaki
Akamine, Hiroyuki
Onishi, Yosuke
Ozawa, Yukiko
Kawaguchi, Naoki
Kubota, Tomoya
Takahashi, Masanori P.
Suzuki, Yasushi
Watanabe, Genya
Kimura, Takashi
Sugimoto, Takamichi
Samukawa, Makoto
Minami, Naoya
Masuda, Masayuki
Konno, Shingo
Nagane, Yuriko
Utsugisawa, Kimiaki
Source :
Journal of Neuroimmunology. Dec2023, Vol. 385, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

This study included 51 patients with muscle-specific kinase antibody-positive myasthenia gravis (MuSK-MG) from a Japanese multicenter survey to examine clinical features and outcomes. Median onset age was 37 years and female predominance was observed. All patients developed generalized symptoms and almost all (50/51) patients had bulbar symptoms. About half of the patients met the criteria for refractory MG. The refractory group had a lower age of onset, higher severity scores, and higher maximum daily doses of oral prednisolone compared to the nonrefractory group. The outcomes for MuSK-MG patients in Japan are not favorable, indicating the need for more aggressive treatment. • MuSK-MG was more common in females. • In MuSK-MG, female patients developed the disease at younger age than male patients. • All MuSK-MG cases were generalized MG, with almost all experiencing bulbar palsy. • The outcomes of patients with MuSK-MG in Japan were unfavorable. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01655728
Volume :
385
Database :
Academic Search Index
Journal :
Journal of Neuroimmunology
Publication Type :
Academic Journal
Accession number :
174159213
Full Text :
https://doi.org/10.1016/j.jneuroim.2023.578241